Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline - Wikidata - awgldk - TriplyDB

Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline

Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline

http://www.wikidata.org/entity/Q41201486

about

Matrix Metalloproteinase 9 (MMP-9) Regulates Vein Wall Biomechanics in Murine Thrombus Resolution Novel microspheres reduce the formation of deep venous thrombosis and repair the vascular wall in a rat model.Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.Recanalization and flow regulate venous thrombus resolution and matrix metalloproteinase expression in vivo Activated protein C accelerates venous thrombus resolution through heme oxygenase-1 induction Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

P2860

Q28548467-5973E520-3878-48CA-8D7E-71B8DDA55B24 Q30491156-34548CA4-E479-428D-A2E6-026889959FEC Q34324817-5D4FD5D4-9772-44A3-BB18-8F8CB91734E6 Q35788548-007F19E4-0627-463E-A261-7AA1BE579D1D Q36967568-919D6144-0A88-45F1-89E8-4F4301C083C2 Q37477690-526934F0-EA10-4EC5-B110-29ADD742551B Q41879259-65A7ED7C-D9D8-4436-A4FA-2620C62DE4A0 Q41892701-2941E26F-AB5D-488A-B75C-7BC1D9691120 Q43119936-A28AE191-3071-48E8-963A-FF2705B961A2

P2860

Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline

http://www.wikidata.org/entity/Q41201486

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Vein wall remodeling after dee ...... weight heparin and doxycycline

@en

type

label

Vein wall remodeling after dee ...... weight heparin and doxycycline

@en

prefLabel

Vein wall remodeling after dee ...... weight heparin and doxycycline

@en

P1433

Q41201486-AFFF9F78-CF1F-4972-8179-2B29A39D4860

P1476

Q41201486-29926914-BD77-49B4-A73E-39C8587FDA36

P2093

Q41201486-0EDE25D2-D54A-4E9A-BE25-1A54EF5E3F4B

Q41201486-4B166269-0648-4211-8DBC-69F189FF0EBE

Q41201486-523D4E4C-532C-4918-8305-7A06F5E62A34

Q41201486-750E67A1-CBF1-43DD-B2B5-2D5970BC91AB

Q41201486-7A56A86B-D69E-4771-B3DD-10B4E9A3D8B7

Q41201486-8DCE127A-C29B-4FCE-833B-78EE03A9E84D

Q41201486-A2F72BCA-52C2-4952-ADBF-C54CB4132EAF

P2860

Q41201486-024593F7-20B4-46E3-8804-71B961E9FA9A

Q41201486-0272FBE3-339C-41BD-9D74-21954663F316

Q41201486-06FDD4F9-FD23-45E7-BB96-2BED7CB7B34C

Q41201486-0D2EAED5-DF30-434B-9994-0A3581C0065F

Q41201486-0FAF2F53-B4B3-462E-8A67-19C740DC4AF8

Q41201486-1544AB99-AC78-40DD-86E9-BC8ADBCDAE7C

Q41201486-1C4D7D6E-6F86-444E-87C6-35E4959D3974

Q41201486-25A9CEC1-7DBB-41BD-8F63-3313618D61C1

Q41201486-2D3EC62A-7D24-44D7-BA4B-89FA26E07583

Q41201486-32A5B5F5-6A3C-4122-A43D-A4677E5A7A92

P304

Q41201486-35263C8C-6AFD-4B11-93DE-D96AA3D960D0

P31

Q41201486-5B93ACD8-E128-45D8-8231-65D2C5018FE2

P356

Q41201486-00F5AB2A-8DAE-44CA-AAFB-901FD90F231F

P433

Q41201486-959E0A32-7FBB-4856-859F-2A8BF48C913E

P478

Q41201486-3DC95938-9B64-45DB-A636-14409C62EE8C

P50

Q41201486-DD662FEE-84D0-49FF-8F21-702DD47909F6

P577

Q41201486-C97E9470-127A-4F50-91A5-FF14E10FECF8

P5875

Q41201486-C0762E77-9A6A-473E-B7AF-A869586106E7

P698

Q41201486-8A338404-F763-4651-83C4-4F65BC157C43

P921

Q41201486-80AAA880-E338-432D-9088-A5BE0BFB362B

P932

Q41201486-EBF7A702-B7F3-4E77-9000-A2747731B0D0

P356

J.AVSG.2009.11.002

P1433

Annals of Vascular Surgery

P1476

Vein wall remodeling after dee ...... weight heparin and doxycycline

@en

P2093

Cathy Luke

http://www.w3.org/2001/XMLSchema#string

Dan D Myers

http://www.w3.org/2001/XMLSchema#string

Erin Miller

http://www.w3.org/2001/XMLSchema#string

Mayo Mitsuya

http://www.w3.org/2001/XMLSchema#string

Peter K Henke

http://www.w3.org/2001/XMLSchema#string

Thomas W Wakefield

http://www.w3.org/2001/XMLSchema#string

Vikram Sood

http://www.w3.org/2001/XMLSchema#string

P2860

Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Effect of heparin and related glycosaminoglycan on PDGF-induced lung fibroblast proliferation, chemotactic response and matrix metalloproteinases activity

Doxycycline inhibition of interleukin-1 in the corneal epithelium.

Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis.

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

New links between inflammation and thrombosis.

Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms.

Oral anticoagulant drugs.

P304

233-241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AVSG.2009.11.002

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Gilbert R Upchurch

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41416344

http://www.w3.org/2001/XMLSchema#string

P698

20142002

http://www.w3.org/2001/XMLSchema#string

P921

P932

2997482

http://www.w3.org/2001/XMLSchema#string